Works by Yoshida, Kazuhiko


Results: 171
    1
    2

    Prognostic Impact of the Administration of Antibiotics and Proton Pump Inhibitors in Immune Checkpoint Inhibitor Combination Therapy for Advanced Renal Cell Carcinoma.

    Published in:
    Cancer Diagnosis & Prognosis, 2024, v. 4, n. 4, p. 496, doi. 10.21873/cdp.10354
    By:
    • NANAKA KATSURAYAMA;
    • HIROKI ISHIHARA;
    • RYO ISHIYAMA;
    • YUKI NEMOTO;
    • TAKASHI IKEDA;
    • SHINSUKE MIZOGUCHI;
    • TAKAYUKI NAKAYAMA;
    • HIRONORI FUKUDA;
    • KAZUHIKO YOSHIDA;
    • JUNPEI IIZUKA;
    • HIROAKI SHINMURA;
    • YASUNOBU HASHIMOTO;
    • TSUNENORI KONDO;
    • TOSHIO TAKAGI
    Publication type:
    Article
    3
    4
    5
    6
    7
    8

    Therapeutic role of deferred cytoreductive nephrectomy in patients with metastatic renal cell carcinoma treated with nivolumab plus ipilimumab.

    Published in:
    Japanese Journal of Clinical Oncology, 2022, v. 52, n. 10, p. 1208, doi. 10.1093/jjco/hyac099
    By:
    • Yoshino, Maki;
    • Ishihara, Hiroki;
    • Nemoto, Yuki;
    • Nakamura, Kazutaka;
    • Nishimura, Koichi;
    • Tachibana, Hidekazu;
    • Fukuda, Hironori;
    • Toki, Daisuke;
    • Yoshida, Kazuhiko;
    • Kobayashi, Hirohito;
    • Iizuka, Junpei;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Tanabe, Kazunari;
    • Kondo, Tsunenori;
    • Takagi, Toshio
    Publication type:
    Article
    9
    10
    11

    Association of tumor burden with outcome in first-line therapy with nivolumab plus ipilimumab for previously untreated metastatic renal cell carcinoma.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 12, p. 1751, doi. 10.1093/jjco/hyab142
    By:
    • Ishihara, Hiroki;
    • Kondo, Tsunenori;
    • Nakamura, Kazutaka;
    • Nemoto, Yuki;
    • Tachibana, Hidekazu;
    • Fukuda, Hironori;
    • Yoshida, Kazuhiko;
    • Kobayashi, Hirohito;
    • Iizuka, Junpei;
    • Shimmura, Hiroaki;
    • Hashimoto, Yasunobu;
    • Tanabe, Kazunari;
    • Takagi, Toshio
    Publication type:
    Article
    12
    13
    14
    15

    Assessing improvements in metastatic renal cell carcinoma systemic treatments from the pre-cytokine to the immune checkpoint inhibitor eras: a retrospective analysis of real-world data.

    Published in:
    Japanese Journal of Clinical Oncology, 2021, v. 51, n. 5, p. 793, doi. 10.1093/jjco/hyaa232
    By:
    • Ishihara, Hiroki;
    • Takagi, Toshio;
    • Kondo, Tsunenori;
    • Fukuda, Hironori;
    • Tachibana, Hidekazu;
    • Yoshida, Kazuhiko;
    • Iizuka, Junpei;
    • Kobayashi, Hirohito;
    • Okumi, Masayoshi;
    • Ishida, Hideki;
    • Tanabe, Kazunari
    Publication type:
    Article
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27
    28

    Melanocytoma in the orbital apex.

    Published in:
    Journal of Neuro-Oncology, 2009, v. 92, n. 1, p. 107, doi. 10.1007/s11060-008-9723-1
    By:
    • Kazufumi Sato;
    • Toshihiko Kubota;
    • Toshiaki Kodera;
    • Ryuhei Kitai;
    • Hiroaki Takeuchi;
    • Kazuhiko Yoshida
    Publication type:
    Article
    29
    30

    A propensity score-matched comparison of surgical precision obtained by using volumetric analysis between robot-assisted laparoscopic and open partial nephrectomy for T1 renal cell carcinoma: a retrospective non-randomized observational study of initial outcomes

    Published in:
    International Urology & Nephrology, 2016, v. 48, n. 10, p. 1585, doi. 10.1007/s11255-016-1323-y
    By:
    • Takagi, Toshio;
    • Kondo, Tsunenori;
    • Tachibana, Hidekazu;
    • Iizuka, Junpei;
    • Omae, Kenji;
    • Kobayashi, Hirohito;
    • Yoshida, Kazuhiko;
    • Hashimoto, Yasunobu;
    • Tanabe, Kazunari
    Publication type:
    Article
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48
    49
    50